Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Medavail Hldg Inc (MDVL)

Medavail Hldg Inc (MDVL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 62,097
  • Shares Outstanding, K 80,022
  • Annual Sales, $ 22,130 K
  • Annual Income, $ -43,820 K
  • 60-Month Beta 0.26
  • Price/Sales 2.88
  • Price/Cash Flow N/A
  • Price/Book 1.72
Trade MDVL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.29
  • Most Recent Earnings -0.17 on 08/11/22
  • Next Earnings Date 11/14/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 74.01%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,252.29% on 08/18/22
  • IV Low 0.00% on 10/03/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 11,610
  • Open Int (30-Day) 11,650

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +293,923.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7010 +15.41%
on 09/27/22
1.2000 -32.58%
on 09/06/22
-0.3610 (-30.85%)
since 09/02/22
3-Month
0.7010 +15.41%
on 09/27/22
1.5900 -49.12%
on 07/19/22
-0.7810 (-49.12%)
since 07/01/22
52-Week
0.7010 +15.41%
on 09/27/22
3.5600 -77.28%
on 04/21/22
-2.2710 (-73.73%)
since 10/01/21

Most Recent Stories

More News
MedAvail to Present at the H.C. Wainwright 24th Annual Global Investment Conference

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company, today announced that the company will be participating in the upcoming hybrid H.C. Wainwright 24 th...

MDVL : 0.8090 (+4.25%)
MedAvail to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth...

MDVL : 0.8090 (+4.25%)
MedAvail Reports Second Quarter 2022 Financial Results

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today reported financial results for the three months ended June 30, 2022.

MDVL : 0.8090 (+4.25%)
MedAvail to Report 2022 Second Quarter Financial Results on August 11, 2022

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the second quarter of 2022 on Thursday, August 11, 2022,...

MDVL : 0.8090 (+4.25%)
MedAvail to Participate in Upcoming Investor Conferences

(Nasdaq: MDVL)— MedAvail Holdings, Inc. (“MedAvail”), a technology-enabled retail pharmacy company, today announced that the company will be participating in the following virtual investor conferences....

MDVL : 0.8090 (+4.25%)
Is MedAvail (MDVL) Outperforming Other Medical Stocks This Year?

Here is how MedAvail Holdings, Inc. (MDVL) and Mirum Pharmaceuticals, Inc. (MIRM) have performed compared to their sector so far this year.

MDVL : 0.8090 (+4.25%)
MIRM : 21.62 (+2.90%)
MedAvail Reports First Quarter 2022 Financial Results

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today reported financial results for the three months ended March 31, 2022.

MDVL : 0.8090 (+4.25%)
MedAvail to Report 2022 First Quarter Financial Results on May 12, 2022

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the first quarter of 2022 on Thursday, May 12, 2022,...

MDVL : 0.8090 (+4.25%)
Has Galapagos (GLPG) Outpaced Other Medical Stocks This Year?

Here is how Galapagos NV (GLPG) and MedAvail Holdings, Inc. (MDVL) have performed compared to their sector so far this year.

GLPG : 42.85 (+0.49%)
MDVL : 0.8090 (+4.25%)
MedAvail Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

(Nasdaq: MDVL)— MedAvail Holdings, Inc. (“MedAvail”), a technology-enabled retail pharmacy company, today announced that on April 8, 2022, the compensation committee of MedAvail’s board of directors...

MDVL : 0.8090 (+4.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

MedAvail Holding Inc. is a technology-enabled pharmacy organization. It engages in providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter and home delivery operations, to Medicare clinics. MedAvail Holding Inc., formerly known as MYOS...

See More

Key Turning Points

3rd Resistance Point 0.9603
2nd Resistance Point 0.8905
1st Resistance Point 0.8497
Last Price 0.8090
1st Support Level 0.7391
2nd Support Level 0.6693
3rd Support Level 0.6285

See More

52-Week High 3.5600
Fibonacci 61.8% 2.4679
Fibonacci 50% 2.1305
Fibonacci 38.2% 1.7931
Last Price 0.8090
52-Week Low 0.7010

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar